SLV.WA Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 11:00):

Stats
Today's Volume	1 357.00
Average Volume	5 575.00
Market Cap	1.29B
EPS	PLN-0.233 ( 2023-11-15 )
Last Dividend	PLN0 ( N/A )
Next Dividend	PLN0 ( N/A )
P/E	57.93
ATR14	PLN0.431 (0.62%)

Selvita S.A. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Selvita S.A. Correlation - Currency/Commodity

0.23
( neutral )

0.10
( neutral )

0.00
( neutral )

0.05
( neutral )

0.30
( neutral )

0.17
( neutral )

Selvita S.A. Financials

Annual	2022
Revenue:	PLN407.46M
Gross Profit:	PLN339.07M (83.21 %)
EPS:	PLN0.0170

Q3	2023
Revenue:	PLN82.35M
Gross Profit:	PLN64.80M (78.69 %)
EPS:	PLN-0.230

Q2	2023
Revenue:	PLN87.54M
Gross Profit:	PLN70.47M (80.51 %)
EPS:	PLN0.430

Q1	2023
Revenue:	PLN90.59M
Gross Profit:	PLN70.66M (77.99 %)
EPS:	PLN0.130

Financial Reports:

No articles found.

Selvita S.A.

Selvita S.A. operates as a contract research organization in Poland, rest of Europe, the United States, and internationally. It operates in two segments, Contract Research Organization (CRO) services, and Bioinformatics. The company offers drug discovery services in the areas of assay development and screening, medicinal and synthetic chemistry, computer-aided drug design/ artificial intelligence, structural biology, in vitro/ In Vivo pharmacology, ADME/DMPK and analytical testing. It also provides pharma services in the field of drug testing and bioanalytical analysis, including development and optimization, validation and transfer, stability studies, quality control, and regulatory aspects support services. In addition, the company offers research and development services in the areas of process research, laboratory scale custom synthesis of NCEs, industrial chemistry, and synthesis of isotopically labelled compounds, as well as other services for the agrochemical industry. Further, it provides bio-data science and advanced software services to data-driven life science and healthcare organizations. Selvita S.A. was founded in 2007 and is headquartered in Krakow, Poland.